Renaissance of Ketamine
DOI:
https://doi.org/10.56782/pps.242Keywords:
ketamine, status epilepticus, agitation, analgesia, depressionAbstract
The history of ketamine began in the 1960s. Ketamine is a specific anesthetic drug that exhibits analgesia, has a stabilizing impact on the cardiovascular system and does not significantly depress the respiratory system. It is responsible for causing the so-called dissociative effect. The effects of ketamine depend on the dose. Its mechanism of action is based primarily on the blockade of N-methyl D-aspartic acid receptors (NMDA) in the central nervous system. Due to its favorable action profile and small number of contraindications, ketamine is becoming an increasingly popular drug. In medicine, it is commonly used as an analgesic and an anesthetic. Studies conducted over recent years have noted that it can be effective in conditions such as: status epilepticus, status asthmaticus, agitation, alcohol dependence and alcohol withdrawal syndrome, depression, and suicidal thoughts. This paper reviews current reports on the uses of ketamine, beneficial especially to physicians with the specialty in emergency medicine.
Downloads
References
Midega, T.D.; Chaves, R.C.F.; Ashihara, C.; Alencar, R.M.; Queiroz,V.N.F.; Zelezoglo, G.R.; Vilanova, L.C.D.S.; Olivato, G.B.; Cordioli, R.L.; Bravim, B.A.; Corrêa, T.D. Ketamine use in critically ill patients: a narrative review. Rev. Bras. Ter. Intensiva 2022, 34(2), 287-294. DOI: 10.5935/0103-507X.20220027-pt. DOI: https://doi.org/10.5935/0103-507X.20220027-en
Bohatyrewicz, M.; Dudek, M.; Rak, M. Ketalicja w krainie czarów. In Polowanie na goryle… czyli nieoczywista medycyna ratunkowa; PZWL Wydawnictwo lekarskie, Polska, 2019; 211-234, ISBN 978-83-200-5843-7.
Hirota, K.; Lambert, D.G. Ketamine; history and role in anesthetic pharmacology. Neuropharmacology 2022, 216, Art. No: 109171. DOI: 10.1016/j.neuropharm.2022.109171. DOI: https://doi.org/10.1016/j.neuropharm.2022.109171
Zastosowanie ketaminy na oddziale intensywnej terapii (OIT). Available online: https://intensywna.pl/zastosowanie-ketaminy-na-oddziale-intensywnej-terapii-oit/ (accessed on 29.06.2024).
Voss, L.J.; Harvey, M.G.; Sleigh, J.W. Non-NMDA Mechanisms of Analgesia in Ketamine Analogs. Front. Pain Res. (Lausanne) 2022, 3, Art. No: 827372. DOI: 10.3389/fpain.2022.827372. DOI: https://doi.org/10.3389/fpain.2022.827372
Feeney, A.; Papakostas, G.I. Pharmacotherapy: Ketamine and Esketamine. Psychiatr. Clin. North Am. 2023, 46(2), 277-290. DOI: 10.1016/j.psc.2023.02.003. DOI: https://doi.org/10.1016/j.psc.2023.02.003
Thanapaisal S.; Oatts J.; Zhao J.; Perez C.I.; Yang Y.; Porco T.C.; Singh K.; Han Y. Effect of general anaesthesia on intraocular pressure in paediatric patients: a systematic review. Eye 2021, 35, 1205–1212. DOI: https://doi.org/10.1038/s41433-020-1093-8. DOI: https://doi.org/10.1038/s41433-020-1093-8
Silverstein, W.K.; Juurlink, D.N.;, Zipursky, J.S.; Ketamine for the treatment of acute pain. CMAJ 2021, 193(43), Art. No: E1663. DOI: 10.1503/cmaj.210878. DOI: https://doi.org/10.1503/cmaj.210878
Update from the K-hole. Available online: https://emottawablog.com/2018/07/update-from-the-k-hole-ketamine-in-the-ed/ (accessed on 29.06.2024).
Zanza, C.; Piccolella, F.; Racca, F.; Romenskaya, T.; Longhitano, Y.; Franceschi, F.; Savioli, G.; Bertozzi, G.; De Simone, S.; Cipolloni, L.; La Russa, R. Ketamine in Acute Brain Injury: Current Opinion Following Cerebral Circulation and Electrical Activity. Healthcare (Basel) 2022, 10(3), Art. No: 566. DOI: 10.3390/healthcare10030566. DOI: https://doi.org/10.3390/healthcare10030566
Dengler, B.A.; Karam, O.; Barthol, C.A.; Chance, A.; Snider, L.E.; Mundy, C.M.; Bounajem, M.T.; Johnson, W.C.; Maita, M.M.; Mendez-Gomez, P.M.; Seifi, A.; Hafeez, S. Ketamine Boluses Are Associated with a Reduction in Intracranial Pressure and an Increase in Cerebral Perfusion Pressure: A Retrospective Observational Study of Patients with Severe Traumatic Brain Injury. Crit. Care Res. Pract. 2022, 2022, Art. No: 834165. DOI: 10.1155/2022/3834165. DOI: https://doi.org/10.1155/2022/3834165
Laws, J.C.; Vance, E.H.; Betters, K.A.; Anderson, J.J.; Fleishman, S.; Bonfield, C.M.; Wellons, J.C.; Xu, M.; Slaughter, J.C.; Giuse, D.A.; Patel, N.; Jordan, L.C.; Wolf, M.S. Acute Effects of Ketamine on Intracranial Pressure in Children With Severe Traumatic Brain Injury. Crit. Care Med. 2023, 51(5), 563-572. DOI: 10.1097/CCM.0000000000005806. DOI: https://doi.org/10.1097/CCM.0000000000005806
Mazandi, V.M.; Lang, S.S.; Rahman, R.K.; Nishisaki, A.; Beaulieu, F.; Zhang, B.; Griffis, H.; Tucker, A.M.; Storm, P.B.; Heuer, G.G.; Gajjar, A.A.; Ampah, S.B.; Kirschen, M.P.; Topjian, A.A.; Yuan, I.; Francoeur, C.; Kilbaugh, T.J.; Huh, J.W. Co-administration of Ketamine in Pediatric Patients with Neurologic Conditions at Risk for Intracranial Hypertension. Neurocrit. Care 2023, 38(2), 242-253. DOI: 10.1007/s12028-022-01611-2. DOI: https://doi.org/10.1007/s12028-022-01611-2
Motov, S.M.; Vlasica, K.; Middlebrook, I.; LaPietra, A. Pain management in the emergency department: a clinical review. Clin. Exp. Emerg. Med. 2021, 8(4), 268-278. DOI: 10.15441/ceem.21.161. DOI: https://doi.org/10.15441/ceem.21.161
Riccardi, A.; Guarino, M.; Serra, S.; Spampinato, M.D.; Vanni, S.; Shiffer, D.; Voza, A.; Fabbri, A.; De Iaco, F. Study and Research Center of the Italian Society of Emergency Medicine. Narrative Review: Low-Dose Ketamine for Pain Management. J. Clin. Med. 2023, 12(9), Art. No: 3256. DOI: 10.3390/jcm12093256. DOI: https://doi.org/10.3390/jcm12093256
Parvizrad, R.; Nikfar, S. Low-dose ketamine as an analgesic agent in the emergency department: Efficacy and safety. J. Family Med. Prim. Care 2022, 11(10), 6464-6471. DOI: 10.4103/jfmpc.jfmpc_511_22. DOI: https://doi.org/10.4103/jfmpc.jfmpc_511_22
Torres, A.C.; Bebarta, V.S.; April, M.D.; Maddry, J.K.; Herson, P.S.; Bebarta, E.K.; Schauer, S. Ketamine Administration in Prehospital Combat Injured Patients With Traumatic Brain Injury: A 10-Year Report of Survival. Cureus 2020, 12(7), Art. No: e9248. DOI: 10.7759/cureus.9248. DOI: https://doi.org/10.7759/cureus.9248
Ying, M.; Zuo, Y. Efficacy of Low-dose Ketamine for Control of Acute Pain in the Emergency Setting: A Systematic Review and Meta-analysis of Randomized Controlled Trials. West J. Emerg. Med. 2023, 24(3), 644-653. DOI: 10.5811/westjem.2023.2.58368. DOI: https://doi.org/10.5811/WESTJEM.58368
Shi, X.; Zhou, J.; Jiang, H.; Xie, K. Ketamine in the Management of Acute Pain: A Comprehensive Meta-Analysis. J. Coll. Physicians Surg. Pak. 2024, 34(1), 78-85. DOI: 10.29271/jcpsp.2024.01.78. DOI: https://doi.org/10.29271/jcpsp.2024.01.78
Altirkistani, B.A; Ashqar, A.A.; Bahathiq, D.M.; Bougis, S.M.; Aljabri, A.M.; Hanafi, S. The Effectiveness of Ketamine Versus Opioids in Patients With Acute Pain in the Emergency Department: A Systematic Review and Meta-Analysis. Cureus 2023, 15(3), Art. No: e36250. DOI: 10.7759/cureus.36250. DOI: https://doi.org/10.7759/cureus.36250
Jiao, J.; Fan, J.; Zhang, Y.; Chen, L. Efficacy and Safety of Ketamine to Treat Cancer Pain in Adult Patients: A Systematic Review. J. Pain Symptom Manage. 2024, 67(3), e185-e210. DOI: 10.1016/j.jpainsymman.2023.11.004. DOI: https://doi.org/10.1016/j.jpainsymman.2023.11.004
Orhurhu, V.J.; Robert, J.S.; Ly, N.; Cohen, S. P. Ketamine in Acute and Chronic Pain Management. In StatPearls; StatPearls Publishing; Internet, 2024. Available online: https://www.ncbi.nlm.nih.gov/books/NBK539824/ (accessed on 29.06.2024).
Prescott, M.G.; Iakovleva, E.; Simpson, M.R.; Pedersen, S.A.; Munblit, D.; Vallersnes, O.M.; Austad, B. Intranasal analgesia for acute moderate to severe pain in children - a systematic review and meta-analysis. BMC Pediatr. 2023, 23(1), Art. No: 405. DOI: 10.1186/s12887-023-04203-x. DOI: https://doi.org/10.1186/s12887-023-04203-x
Almodibeg, B.; Forget, P. Challenges of acute pain management in older patients. Age Ageing 2024, 53(4), Art. No: afae061. DOI: 10.1093/ageing/afae061. DOI: https://doi.org/10.1093/ageing/afae061
Kunkel, S.; Lenz, T. Hemodynamics in Helicopter Emergency Medical Services (HEMS) Patients Undergoing Rapid Sequence Intubation With Etomidate or Ketamine. J. Emerg. Med. 2022, 62(2), 163-170. DOI: 10.1016/j.jemermed.2021.10.004. DOI: https://doi.org/10.1016/j.jemermed.2021.10.004
Kim, J.; Jung, K.; Moon, J.; Kwon, J.; Kang, B.H.; Yoo, J.; Song, S.; Bang, E.; Kim, S.; Huh, Y. Ketamine versus etomidate for rapid sequence intubation in patients with trauma: a retrospective study in a level 1 trauma center in Korea. BMC Emerg. Med. 2023, 23(1), Art. No: 57. DOI: 10.1186/s12873-023-00833-7. DOI: https://doi.org/10.1186/s12873-023-00833-7
Stanke, L.; Nakajima, S.; Zimmerman, L.H.; Collopy, K.; Fales, C.; Powers, W. 4th. Hemodynamic Effects of Ketamine Versus Etomidate for Prehospital Rapid Sequence Intubation. Air Med. J. 2021, 40(5), 312-316. DOI: 10.1016/j.amj.2021.05.009. DOI: https://doi.org/10.1016/j.amj.2021.05.009
Sharda, S.C.; Bhatia, M.S. Etomidate Compared to Ketamine for Induction during Rapid Sequence Intubation: A Systematic Review and Meta-analysis. Indian J. Crit. Care Med. 2022, 26(1), 108-113. DOI: 10.5005/jp-journals-10071-24086. DOI: https://doi.org/10.5005/jp-journals-10071-24086
Sharif, S.; Kang, J.; Sadeghirad, B.; Rizv,i F.; Forestell, B.; Greer, A.; Hewitt, M.; Fernando, S.M.; Mehta, S.; Eltorki, M.; Siemieniuk, R.; Duffett, M.; Bhatt, M.; Burry, L.; Perry, J.J.; Petrosoniak, A.; Pandharipande, P.; Welsford, M.; Rochwerg, B. Pharmacological agents for procedural sedation and analgesia in the emergency department and intensive care unit: a systematic review and network meta-analysis of randomised trials. Br. J. Anaesth. 2024, 132(3), 491-506. DOI: 10.1016/j.bja.2023.11.050. DOI: https://doi.org/10.1016/j.bja.2023.11.050
Zaki, H.A.; Ibrahim, T.; Osman, A.; Elnabawy, W.A.; Gebril, A.; Hamdi, A.H.; Mohamed, E.H. Comparing the Safety and Effectiveness of Ketamine Versus Benzodiazepine/Opioid Combination for Procedural Sedation in Emergency Medicine: A Comprehensive Review and Meta-Analysis. Cureus 2023, 15(3), Art. No: e36742. DOI: 10.7759/cureus.36742. DOI: https://doi.org/10.7759/cureus.36742
Zaki, H.A.; Shallik, N.; Shaban, E.; Bashir, K.; Iftikhar, H.; Mohamed Khair, Y.; Abdelrahim, M.G.; Fayed, M.; Hendy, M.; Salem, E.E.; Elmoheen, A. An Analytical Comparison Between Ketamine Alone and a Combination of Ketamine and Propofol (Ketofol) for Procedural Sedation and Analgesia From an Emergency Perspective: A Systematic Review and Meta-Analysis. Cureus 2022, 14(7), Art. No: e27318. DOI: 10.7759/cureus.27318. DOI: https://doi.org/10.7759/cureus.27318
Choi, E.J.; Kim, C.H.; Yoon, J.Y.; Kim, E.J. Ketamine-propofol (ketofol) in procedural sedation: a narrative review. J. Dent. Anesth. Pain Med. 2023, 23(3), 123-133. DOI: 10.17245/jdapm.2023.23.3.123. DOI: https://doi.org/10.17245/jdapm.2023.23.3.123
Maheswari, N.; Panda, N.B.; Mahajan, S.; Luthra, A.; Pattnaik, S.; Bhatia, N.; Karthigeyan, M.; Kaloria, N.; Chauhan, R.; Soni, S.; Jangra, K.; Bhagat, H. Ketofol as an Anesthetic Agent in Patients With Isolated Moderate to Severe Traumatic Brain Injury: A Prospective, Randomized Double-blind Controlled Trial. J. Neurosurg. Anesthesiol. 2023, 35(1), 49-55. DOI: 10.1097/ANA.0000000000000774. DOI: https://doi.org/10.1097/ANA.0000000000000774
Biliškov, A.N.; Ivančev, B.; Pogorelić, Z. Effects on Recovery of Pediatric Patients Undergoing Total Intravenous Anesthesia with Propofol versus Ketofol for Short-Lasting Laparoscopic Procedures. Children (Basel) 2021, 8(7), Art. No: 610. DOI: 10.3390/children8070610. DOI: https://doi.org/10.3390/children8070610
Strayer, R.J. Current concepts in ketamine therapy in the emergency department. Emerg. Med. Pract. 2024, 26(5), 1-24.
García-Ruiz, M.; Rodríguez, P.M.; Palliotti, L.; Lastras, C.; Romeral-Jiménez, M.; Morales, I.G.; Rey, C.P.; Rodrigo-Gisbert, M.; Campos-Fernández, D.; Santamarina, E.; Carbonell, B.P. Ketamine in the treatment of refractory and super-refractory status epilepticus: Experience from two centres. Seizure 2024, 117, 13-19. DOI: 10.1016/j.seizure.2024.01.013. DOI: https://doi.org/10.1016/j.seizure.2024.01.013
Buratti, S.; Giacheri, E.; Palmieri, A.; Tibaldi, J.; Brisca, G.; Riva, A.; Striano, P.; Mancardi, M.M.; Nobili, L.; Moscatelli, A. Ketamine as advanced second-line treatment in benzodiazepine-refractory convulsive status epilepticus in children. Epilepsia 2023, 64(4), 797-810. DOI: 10.1111/epi.17550. DOI: https://doi.org/10.1111/epi.17550
Espinosa, L.; Gomez, M.; Zamora, A.; Molano-Franco, D. Refractory and super-refractory status epilepticus and evidence for the use of ketamine: a scope review. J. Neurocrit. Care 2023, 16(1), 1-9. DOI: 10.18700/jnc.230003. DOI: https://doi.org/10.18700/jnc.230003
Heuser, K.; Olsen, K.B.; Ulvin, L.B.; Gjerstad, L.; Erik Taubøll, E. Modern Treatment of Status Epilepticus in Adults. In: Czuczwar SJ, editor. Epilepsy [Internet]. Brisbane (AU): Exon Publications; 2022 Apr 2. Chapter 5. Available online: https://www.ncbi.nlm.nih.gov/books/NBK580620/ DOI: 10.36255/exon-publications-epilepsy-status-epilepticus. DOI: https://doi.org/10.36255/exon-publications-epilepsy-status-epilepticus
Besha, A.; Adamu, Y.; Mulugeta, H.; Zemedkun, A.; Destaw, B. Evidence-based guideline on management of status epilepticus in adult intensive care unit in resource-limited settings: a review article. Ann. Med. Surg. (Lond.) 2023, 85(6), 2714-2720. DOI: 10.1097/MS9.0000000000000625. DOI: https://doi.org/10.1097/MS9.0000000000000625
What is the role of ketamine in the management of status epilepticus? Available online: https://dig.pharmacy.uic.edu/faqs/2023-2/december-2023-faqs/what-is-the-role-of-ketamine-in-the-management-of-status-epilepticus/ (accessed on 29.06.2024).
Williams, N.C.; Morgan, L.A.; Friedman, J.; Siegler, J. Ketamine Efficacy for Management of Status Epilepticus: Considerations for Prehospital Clinicians. Air Med. J. 2024, 43(2), 84-89. DOI: 10.1016/j.amj.2023.09.011. DOI: https://doi.org/10.1016/j.amj.2023.09.011
Jacobwitz, M.; Mulvihill, C.; Kaufman, M.C.; Gonzalez, A.K.; Resendiz, K.; MacDonald, J.M.; Francoeur, C.; Helbig, I.; Topjian, A.A.; Abend, N.S. Ketamine for Management of Neonatal and Pediatric Refractory Status Epilepticus. Neurology 2022, 99(12), e1227-e1238. DOI: 10.1212/WNL.0000000000200889. DOI: https://doi.org/10.1212/WNL.0000000000200889
Van de Voorde, P.; Turner, N.M.; Djakow, J.; de Lucas, N.; Martinez-Mejias, A.; Biarent, D.; Bingham, R., Brissaud, O.; Hoffmann, F.; Johannesdottirl, G.B.; Lauritsen, T.; Maconochie, I. European Resuscitation Council Guidelines 2021: Paediatric Life Support. Resuscitation 2021, 161, 327-387. DOI: 10.1016/j.resuscitation.2021.02.015 DOI: https://doi.org/10.1016/j.resuscitation.2021.02.015
Chakraborty, R.K.; Chen, R.J.; Basnet, S. Status Asthmaticus. 2024 Feb 9. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. Available online: https://www.ncbi.nlm.nih.gov/books/NBK526070/ (accessed on 29.06.2024).
Garner, O.; Ramey, J.S.; Hanania, N.A. Management of Life-Threatening Asthma: Severe Asthma Series. Chest 2022, 162(4), 747-756. DOI: 10.1016/j.chest.2022.02.029. DOI: https://doi.org/10.1016/j.chest.2022.02.029
La Via, L.; Sanfilippo, F.; Cuttone, G.; Dezio, V.; Falcone, M.; Brancati, S.; Crimi, C.; Astuto, M. Use of ketamine in patients with refractory severe asthma exacerbations: systematic review of prospective studies. Eur. J. Clin. Pharmacol. 2022, 78, 1613–1622. DOI: https://doi.org/10.1007/s00228-022-03374-3. DOI: https://doi.org/10.1007/s00228-022-03374-3
Nedel, W.; Costa, R.; Mendez, G.; Marin, L.; Vargas, T.; Marques, L. Negative results for ketamine use in severe acute bronchospasm: a randomised controlled trial. Anaesthesiol. Intensive Ther. 2020, 52(3), 215-218. DOI: 10.5114/ait.2020.97765. DOI: https://doi.org/10.5114/ait.2020.97765
Simon, E.L.; Smalley, C.M.; Muir, M.; Mangira, C.M.; Pence, R.; Wahi-Singh, B.; Delgado, F.; Fertel, B.S. Agitation Management in the Emergency Department with Physical Restraints: Where Do These Patients End Up? West J. Emerg. Med. 2023, 24(3), 454-460. DOI: 10.5811/westjem.59466. DOI: https://doi.org/10.5811/WESTJEM.59466
Corwell, B.N.; Motov, S.M.; Davis, N.L.; Kim, H.K. Novel uses of ketamine in the emergency department. Expert Opin. Drug Saf. 2022, 21(8), 1009-1025. DOI: 10.1080/14740338.2022.2100883. DOI: https://doi.org/10.1080/14740338.2022.2100883
Curry, A.; Malas, N.; Mroczkowski, M.; Hong, V. Nordstrom K.; Terrell C. Updates in the Assessment and Management of Agitation. Focus (Am. Psychiatr. Publ.) 2023, 21(1), 35-45. DOI: 10.1176/appi.focus.20220064 DOI: https://doi.org/10.1176/appi.focus.20220064
Barbic, D.; Andolfatto, G.; Grunau, B.; Scheuermeyer, F.X.; Macewan, B.; Qian, H.; Wong, H.; Barbic, S.P; Honer, W.G. Rapid Agitation Control With Ketamine in the Emergency Department: A Blinded, Randomized Controlled Trial. Ann. Emerg. Med. 2021, 78(6), 788-795. DOI: 10.1016/j.annemergmed.2021.05.023. DOI: https://doi.org/10.1016/j.annemergmed.2021.05.023
Lin, J.; Figuerado, Y.; Montgomery, A.; Lee, J.; Cannis, M.; Norton, V.C.; Calvo, R.; Sikand, H. Efficacy of ketamine for initial control of acute agitation in the emergency department: A randomized study. Am. J. Emerg. Med. 2021, 44, 306-311. DOI: 10.1016/j.ajem.2020.04.013. DOI: https://doi.org/10.1016/j.ajem.2020.04.013
Kim, H. K.; Leonard, J. B.; Corwell, B. N.; Connors, N. J. Safety and efficacy of pharmacologic agents used for rapid tranquilization of emergency department patients with acute agitation or excited delirium. Expert Opin. Drug Saf. 2021, 20(2), 123–138. DOI: 10.1080/14740338.2021.1865911. DOI: https://doi.org/10.1080/14740338.2021.1865911
Garel, N.; McAnulty, C.; Greenway, K.T.; Lesperance, P.; Miron, J.P.; Rej, S.; Richard-Devantoy, S.; Jutras-Aswad, D. Efficacy of ketamine intervention to decrease alcohol use, cravings, and withdrawal symptoms in adults with problematic alcohol use or alcohol use disorder: A systematic review and comprehensive analysis of mechanism of actions. Drug Alcohol Depend. 2022, 239, Art. No: 109606. DOI:10.1016/j.drugalcdep.2022.109606. DOI: https://doi.org/10.1016/j.drugalcdep.2022.109606
Goldfine, C.E.; Tom, J.J.; Im, D.D.; Yudkoff, B.; Anand, A.; Taylor, J.J.; Chai, P.R; Suzuki, J. The therapeutic use and efficacy of ketamine in alcohol use disorder and alcohol withdrawal syndrome: a scoping review. Front. Psychiatry 2023, 14, Art. No: 1141836. DOI: 10.3389/fpsyt.2023.1141836. DOI: https://doi.org/10.3389/fpsyt.2023.1141836
Kelson, M.; Burnett, J.M.; Matthews, A.; Juneja, T. Ketamine Treatment for Alcohol Use Disorder: A Systematic Review. Cureus 2023, 15(5), Art. No: e38498. DOI: 10.7759/cureus.38498. DOI: https://doi.org/10.7759/cureus.38498
Tran, K.; MacDougall, D. Ketamine for Adults With Substance Use Disorders: Rapid Review [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2024 Feb. Available online: https://www.ncbi.nlm.nih.gov/books/NBK602506/ (accessed on 29.06.2024)
Sajid, S.; Lawrence, R.E.; Galfalvy, H.C.; Keilp, J.G.; Moitra, V.K.; Mann, J.J.; Grunebaum, M.F. Intramuscular ketamine vs. midazolam for rapid risk-reduction in suicidal, depressed emergency patients: Clinical trial design and rationale. J. Affect. Disord. Rep. 2024, 15, Art. No: 100690. DOI: 10.1016/j.jadr.2023.100690. DOI: https://doi.org/10.1016/j.jadr.2023.100690
Whitaker, T.; Farrand, K.F.; Thase, M.E. A Phase 2 Open Label Study of Efficacy, Safety, and Tolerability of SLS-002 (Intranasal Racemic Ketamine) in Adults with MDD at Imminent Risk of Suicide. Psychopharmacol. Bull. 2024, 54(1), 8-17.
Kumari, S.; Chaudhry, H.A.; Sagot, A.; Doumas, S.; Abdullah, H.; Alcera, E.; Solhkhah, R.; Afzal, S. Exploring Esketamine's Therapeutic Outcomes as an FDA-Designated Breakthrough for Treatment-Resistant Depression and Major Depressive Disorder With Suicidal Intent: A Narrative Review. Cureus 2024, 16(2), Art. No: e53987. DOI: 10.7759/cureus.53987. DOI: https://doi.org/10.7759/cureus.53987
Anzolin, A.P.; Baldez, D.P.; Montezano, B.B.; Kapczinski, F.; de Abreu, P.B.; Kauer-Sant'Anna, M. Subcutaneous ketamine reduces suicide risk and improves functioning in depression: A proof-of-concept study. Psychiatry Res. 2024, 337. Art. No: 115915. DOI: 10.1016/j.psychres.2024.115915. DOI: https://doi.org/10.1016/j.psychres.2024.115915
Shen, Z.; Gao, D.; Lv, X.; Wang, H.; Yue W. A meta-analysis of the effects of ketamine on suicidal ideation in depression patients. Transl. Psychiatry 2024, 14(1), Art. No: 248. DOI: 10.1038/s41398-024-02973-1. DOI: https://doi.org/10.1038/s41398-024-02973-1
Zolghadriha, A.; Anjomshoaa, A.; Jamshidi, M.R.; Taherkhani, F. Rapid and sustained antidepressant effects of intravenous ketamine in treatment-resistant major depressive disorder and suicidal ideation: a randomized clinical trial. BMC Psychiatry 2024, 24(1), Art. No: 341. DOI: 10.1186/s12888-024-05716-0. DOI: https://doi.org/10.1186/s12888-024-05716-0
Wang, Y.T.; Wang, X.L.; Lei, L.; Guo, Z.Y.; Kan, F.F.; Hu, D.; Gai, C.; Zhang, Y. A systematic review and meta-analysis of the efficacy of ketamine and esketamine on suicidal ideation in treatment-resistant depression. Eur. J. Clin. Pharmacol. 2024, 80(2), 287-296. DOI: 10.1007/s00228-023-03605-1. DOI: https://doi.org/10.1007/s00228-023-03605-1
McIntyre, R.S.; Mansur, R.B.; Rosenblat, J.D.; Teopiz, K.M.; Kwan, A.T.H. The association between ketamine and esketamine and suicidality: reports to the Food And Drug Administration Adverse Event Reporting System (FAERS). Expert Opin. Drug Saf. 2024, 1-6. DOI: 10.1080/14740338.2024.2368827. DOI: https://doi.org/10.1080/14740338.2024.2368827
Bruton, A.M.; Wesemann, D.G.; Machingo, T.A.; Majak, G.; Johnstone, J.M.; Marshall, R.D. Ketamine for mood disorders, anxiety, and suicidality in children and adolescents: a systematic review. Eur. Child Adolesc. Psychiatry 2024. DOI: 10.1007/s00787-024-02458-y. DOI: https://doi.org/10.1007/s00787-024-02458-y
Emslie, G.J. Editorial: Novel Approaches to the Treatment of Suicidality and Depression in Youth. J. Am. Acad. Child Adolesc. Psychiatry 2024, 63(5), 500-501. DOI: 10.1016/j.jaac.2023.06.019. DOI: https://doi.org/10.1016/j.jaac.2023.06.019
Seshadri, A.; Prokop, L.J.; Singh, B. Efficacy of intravenous ketamine and intranasal esketamine with dose escalation for Major depression: A systematic review and meta-analysis. J. Affect. Disord. 2024, 356, 379-384. DOI: 10.1016/j.jad.2024.03.137. DOI: https://doi.org/10.1016/j.jad.2024.03.137
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Kinga Kocur, Katarzyna Camlet, Anna Ziobro, Mateusz Ziomek, Wojciech Kaźmierski, Paulina Lis, Jakub Jurek, Anna Lis
This work is licensed under a Creative Commons Attribution 4.0 International License.
For all articles published in Prospects in Pharmaceutical Sciences copyright is retained by the authors. The journal publishes articles in the Open Access policy, within the CC BY 4.0 licence.
This is a human-readable summary of (and not a substitute for) the license. Disclaimer.
You are free to:
Share — copy and redistribute the material in any medium or format
Adapt — remix, transform, and build upon the material for any purpose, even commercially.
The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation.
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
How to Cite
